Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03317067
PHASE3

Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial)

Sponsor: University Hospital, Clermont-Ferrand

View on ClinicalTrials.gov

Summary

The primary purpose of the study is to evaluate whether dexmedetomidine is effective in treating agitated delirium of non-intubated ICI patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

168

Start Date

2017-12-21

Completion Date

2023-02-23

Last Updated

2026-05-13

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine

The 4D trial is an investigator-initiated, prospective, multicenter, randomized, double-blinded, two-arm trial, randomizing 300 non-intubated ICU patients with diagnosis of agitated delirium to receive dexmedetomidine or placebo as a cure

OTHER

Placebo

The 4D trial is an investigator-initiated, prospective, multicenter, randomized, double-blinded, two-arm trial, randomizing 300 non-intubated ICU patients with diagnosis of agitated delirium to receive dexmedetomidine or placebo as a cure

Locations (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France